Model
Edge
TherapeuticsMD
TXMD
Filing Type
10-K/A
Filing Date
3/31/2026
Updated
3/31/26, 7:53 PM
Filing
10-K/A
Earnings Release
Exhibits
10-K/A
Amended Annual Report
EX-23.1
CONSENT OF BERKOWITZ POLLACK BRANT
EX-23.2
CONSENT OF CARR, RIGGS & INGRAM, L.L.C.
EX-31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
EX-31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
EX-32.1
SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER
EX-32.2
SECTION 1350 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic